Scientific Literature Search

Source record

Optimizing treatment for Parkinson's disease.

Schapira AH, Tan EK.

Eur J Neurol · 2012-12-01

DOI: 10.1111/ene.12025PMID: 23157243

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Levodopa in the treatment of Parkinson's disease: myths and realties].

Luquin MR, García-Ruiz PJ, Martí MJ, Rojo A, Vela L, Grandas FJ, Bravo-Utrera M, Burguera JA, Chacón JR, Campos-Arillo VM, Durán-Herrera C, Fernández-García JM, García-Ramos R, Gómez-Esteban JC, Gutierrez J, Juni J, Mata M, Martínez-Castrillo JC, Olivares J, Ribacoba-Montero R, Santos-García D, Sierra M, Valero-Merino C.

Rev Neurol · 2012-12-01

DOI: 10.33588/rn.5511.2012398PMID: 23172094

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Effect of cognitive behavior therapy on sleep disorder in Parkinson's disease in China: a pilot study.

Yang H, Petrini M.

Nurs Health Sci · 2012-12-01

DOI: 10.1111/j.1442-2018.2012.00711.xPMID: 23186520

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Transplantation of human retinal pigment epithelium cells in the treatment for Parkinson disease.

Yin F, Tian ZM, Liu S, Zhao QJ, Wang RM, Shen L, Wieman J, Yan Y.

CNS Neurosci Ther · 2012-12-01

DOI: 10.1111/cns.12025PMID: 23190934

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Therapeutic deep brain stimulation in Parkinsonian rats directly influences motor cortex.

Li Q, Ke Y, Chan DC, Qian ZM, Yung KK, Ko H, Arbuthnott GW, Yung WH.

Neuron · 2012-12-01

DOI: 10.1016/j.neuron.2012.09.032PMID: 23217750

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease.

Bagetta V, Sgobio C, Pendolino V, Del Papa G, Tozzi A, Ghiglieri V, Giampà C, Zianni E, Gardoni F, Calabresi P, Picconi B.

J Neurosci · 2012-12-01

DOI: 10.1523/jneurosci.2664-12.2012PMID: 23223310

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Motor profile and drug treatment of nursing home residents with Parkinson's disease.

Weerkamp NJ, Zuidema SU, Tissingh G, Poels PJ, Munneke M, Koopmans RT, Bloem BR.

J Am Geriatr Soc · 2012-12-01

DOI: 10.1111/jgs.12027PMID: 23231550

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implications.

Akhtar RS, Stern MB.

Expert Rev Neurother · 2012-12-01

DOI: 10.1586/ern.12.144PMID: 23237350

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Drug treatments for the neuropsychiatric complications of Parkinson's disease.

Connolly BS, Fox SH.

Expert Rev Neurother · 2012-12-01

DOI: 10.1586/ern.12.142PMID: 23237351

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Subthalamic lesion or levodopa treatment rescues giant GABAergic currents of PINK1-deficient striatum.

Dehorter N, Lozovaya N, Mdzomba BJ, Michel FJ, Lopez C, Tsintsadze V, Tsintsadze T, Klinkenberg M, Gispert S, Auburger G, Hammond C.

J Neurosci · 2012-12-01

DOI: 10.1523/jneurosci.2474-12.2012PMID: 23238720

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

C. elegans as a genetic model system to identify Parkinson's disease-associated therapeutic targets.

Vistbakka J, VanDuyn N, Wong G, Nass R.

CNS Neurol Disord Drug Targets · 2012-12-01

DOI: 10.2174/1871527311211080004PMID: 23244419

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.

Kumar H, Koppula S, Kim IS, More SV, Kim BW, Choi DK.

CNS Neurol Disord Drug Targets · 2012-12-01

DOI: 10.2174/1871527311211080012PMID: 23244425

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

22.728 articles found

Optimizing treatment for Parkinson's disease.

[Levodopa in the treatment of Parkinson's disease: myths and realties].

Effect of cognitive behavior therapy on sleep disorder in Parkinson's disease in China: a pilot study.

Transplantation of human retinal pigment epithelium cells in the treatment for Parkinson disease.

Therapeutic deep brain stimulation in Parkinsonian rats directly influences motor cortex.

Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease.

Motor profile and drug treatment of nursing home residents with Parkinson's disease.

New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implications.

Drug treatments for the neuropsychiatric complications of Parkinson's disease.

Subthalamic lesion or levodopa treatment rescues giant GABAergic currents of PINK1-deficient striatum.

C. elegans as a genetic model system to identify Parkinson's disease-associated therapeutic targets.

Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.

Filters